1. HBW Insight
  2. >>Beauty
  3. >>Policy & Regulation
  4. >>Legal

Overwhelmed J&J Talc Supplier Takes Cover Under Bankruptcy Protections

 
• By Ryan Nelson

“It is simply not in the best interests of our stakeholders to litigate these claims in perpetuity,” says Imerys Talc America President Giorgio La Motta of the company’s decision to reorganize its business and debts under Chapter 11 in negotiation with claimants in cosmetic talc-related suits.

Businessman sinking in heap of documents and asking for help

Imerys Talc America, Inc. and related companies in North America – embroiled in thousands of liability suits around the country, along with customer Johnson & Johnson, from plaintiffs linking their talc to cancer – filed Feb. 13 for protection under Chapter 11 of the US Bankruptcy Code.

According to the firm’s announcement, the voluntary filing in Delaware federal bankruptcy court immediately suspends all outstanding US

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legal

More from Policy & Regulation

US Fragrance Firms Should Identify Domestic, Non-Tariff Sources Now – Fragrance House CEO

Firms in the US facing tariff costs should identify US-based, non-tariff sources and lobby local government officials and DC when foreign-sourced ingredients cannot be substituted in the US.

Cosmetics Consortium Shares Studies With FDA To Build Confidence In Animal Testing Alternatives

 
• By Lauren Nardella

By guiding regulators through case studies and mock dossier examples of how to utilize new approach methodologies, the International Collaboration on Cosmetics Safety hopes to counter hesitations in replacing animal tests.

Stakeholders Hope US FDA’s Proposed Animal Test Phase-Out For Drugs Will Extend To OTCs, Cosmetics

 
• By Eileen Francis and Lauren Nardella

The US Food and Drug Administration has released a roadmap to adopt new approach methodologies in lieu of animal testing for monoclonal antibody therapies and other drugs, which may include OTC drugs though the proposal does not specifically include cosmetics.